uk
uk · page 4
- Companies
Script Assist Unveils Ground-Up Rebuild of UK Medical Cannabis Software
Script Assist, the SaaS platform now used by some of the UK’s leading medical cannabis clinics and prescribing doctors, is set to launch a major ground-up overhaul of its platform.
- Prescribers & Clinics
UK Patient Data Exposed Amid Clinic Data Breach
Originally published on Cannabis Health A UK medical cannabis clinic is carrying out investigations after a substantial amount of patients’ information was leaked in a major data breach.
- Interviews
Legal Medicine Shouldn’t Make You Feel Like a Criminal at the Airport
The UK’s Border Force and airport security services have been on high alert for cannabis coming into and out of the country for some time, following a significant spike in seizures.
- Public Markets
A Tale of Two Markets: German Cannabis Companies Chase Records as UK Operators Seek Exits
As Q2 2025 figures continue to roll in, the stark contrast between companies operating in the UK and Germany are becoming increasingly apparent.
- Medical Cannabis
Not on Our Watch: Releaf Pushes Back Against Rushed Cannabis Prescribing
The British Medical Association (BMA), which represents tens of thousands of General Practitioners in the UK, this week threatened new strike action amid increasing tensions with the Starmer government.
- Interviews
Why Curaleaf Laboratories Believes the UK Medical Cannabis Market Is Still Just Getting Started
As the UK’s medical cannabis patient population pushes past an estimated 60,000, questions about market maturity, patient access, and regulatory reform are more pressing than ever.
- Press releases
Grow Group Transforms UK Cannabis Distribution Landscape with Avida Medical Deal
UK Medical cannabis operator Grow Group has announced a significant expansion of its full-service UK medical cannabis distribution platform, as it launches the newly rebranded Grow Group UK.
- Uncategorized
FSA Shifts Gears: Reformulation, THC Tolerance, and Faster CBD Approvals Appear to Be On the Horizon
This morning, the UK’s Food Standards Agency (FSA) announced some significant updates to its multi-year CBD Novel Foods approvals process, finally offering hundreds of long-suffering businesses some light at the end of the tunnel.
- Press releases
Glass Pharms Signs Supply Deal with Mamedica in ‘Milestone for UK Cultivation’
Under the collaboration, Glass Pharms will supply high-quality cannabis flower for use in Mamedica-branded, clinician-prescribed products, reinforcing the value of a fully domestic supply chain for CBPMs (Cannabis-Based Products for Medicinal Use).
- Uncategorized
Cost vs Care: Can Clinics Stay Affordable While Scaling Responsibly?
Medical cannabis clinics are often driven to scale their operations quickly, out of a desire to reach more patients who could benefit from treatment and the need to remain affordable for them. But doing so shouldn’t come at the cost of regulatory compliance.
- Data & Analysis
What Comes Next for UK Medical Cannabis?
Though large-scale reform does not currently appear forthcoming, there are small-scale, more targeted measures that could feasibly be taken by UK authorities in the coming years which would be positive for the medical cannabis industry.
- Uncategorized
Much-Needed Or More Delays? UK Industry Responds to Upcoming ACMD Review of Cannabis-Based Medicines
The UK government has commissioned the Advisory Council on the Misuse of Drugs (ACMD) to carry out a formal review of the current state of play regarding cannabis-based medicinal products.
